StockData
Korsana Biosciences, Inc. logo

Korsana Biosciences, Inc. (KRSA) stock

KRSANasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 6/30493% above fair value
$33.27+0.77 (+2.37%)

Close on Nov 18, 2026Market cap $155.75MP/E –Yield –

Korsana Biosciences operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

Korsana Biosciences's operating income for the twelve months ending Jun 30, 2026 was -$6.82M. For fiscal 2025 it was -$4.97M. The highest annual figure on record is -$3.63M in fiscal 2024.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025-$4.97M–
FY2024Dec 31, 2024-$3.63M–
FY2023Dec 31, 2023-$12.95M–
FY2022Dec 31, 2022-$18.54M–
FY2021Dec 31, 2021-$55.20M–
FY2020Dec 31, 2020-$81.27M–
FY2019Dec 31, 2019-$125.04M–
FY2018Dec 31, 2018-$115.25M–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q2 FY2026Jun 30, 2026-$1.77M–
Q1 FY2026Mar 31, 2026-$3.21M–
Q4 FY2025Dec 31, 2025-$838.00K-266.9%
Q3 FY2025Sep 30, 2025-$1.01M–
Q2 FY2025Jun 30, 2025-$1.67M–
Q1 FY2025Mar 31, 2025-$1.46M–
Q4 FY2024Dec 31, 2024$502.00K–
Q3 FY2024Sep 30, 2024-$1.13M–
Q2 FY2024Jun 30, 2024-$1.38M–
Q1 FY2024Mar 31, 2024-$1.62M–
Q4 FY2023Dec 31, 2023-$1.80M–
Q3 FY2023Sep 30, 2023-$6.02M–
Q2 FY2023Jun 30, 2023-$1.87M–
Q1 FY2023Mar 31, 2023-$3.28M–
Q4 FY2022Dec 31, 2022-$4.46M–
Q3 FY2022Sep 30, 2022-$4.52M–
Q2 FY2022Jun 30, 2022-$13.43M–
Q1 FY2022Mar 31, 2022-$12.98M–
Q4 FY2021Dec 31, 2021-$14.34M–
Q3 FY2021Sep 30, 2021-$11.29M–
Q2 FY2021Jun 30, 2021-$16.18M–
Q1 FY2021Mar 31, 2021-$13.40M–
Q4 FY2020Dec 31, 2020-$19.22M–
Q3 FY2020Sep 30, 2020-$21.78M–
Q2 FY2020Jun 30, 2020-$19.67M–
Q1 FY2020Mar 31, 2020-$20.59M–
Q4 FY2019Dec 31, 2019-$26.59M–
Q3 FY2019Sep 30, 2019-$28.02M–
Q2 FY2019Jun 30, 2019-$33.05M–
Q1 FY2019Mar 31, 2019-$37.38M–
Q4 FY2018Dec 31, 2018-$30.90M–
Q3 FY2018Sep 30, 2018-$29.29M–
Q2 FY2018Jun 30, 2018-$29.78M–
Q1 FY2018Mar 31, 2018-$25.28M–

More Korsana Biosciences figures

See a number that looks wrong?